Citation: | REN Ke, TIAN Lijun, HUANG Xiaoying, HAN Xudong, ZHANG Ying. Value of indicators including serum neuron-specific enolase in assessing prognosis of patients with cirrhosis complicated by overt hepatic encephalopathy[J]. Journal of Clinical Medicine in Practice, 2024, 28(17): 35-40. DOI: 10.7619/jcmp.20241108 |
To investigate the predictive value of serum neuron-specific enolase (NSE), prognostic nutritional index (PNI) score, hepatic encephalopathy (HE) grading, and the integrated model for end-stage liver disease (iMELD) score in assessing the short-term (90-day) prognosis of patients with cirrhosis complicated by overt hepatic encephalopathy (HE).
A retrospective analysis was conducted on clinical data from 470 patients with cirrhosis and overt HE, and they were divided into survival group (n=359) and mortality group (n=111) based on their survival status 90 days after admission. The PNI and iMELD scores were calculated using patient demographics, blood routine tests, coagulation function, liver and renal function electrolyte levels, and serum NSE levels within 24 hours of admission, along with HE grading. Receiver operating characteristic (ROC) curves, multivariate Logistic regression analysis, and Kaplan-Meier survival curves were employed to evaluate influencing factors of short-term prognosis of patients with cirrhosis and overt HE.
The mortality group exhibited significantly higher serum NSE levels, HE grades, and iMELD scores, while demonstrated lower PNI score compared to the survival group (P < 0.05). Multivariate Logistic regression analysis identified serum NSE, PNI score, HE grade, and iMELD score as independent predictors of short-term prognosis. The areas under the curve (AUCs) for serum NSE, PNI score, HE grade, and iMELD score in predicting short-term prognosis were 0.727, 0.717, 0.721, and 0.728, respectively, with cut-off values of 12.23 ng/mL, 34.05 ng/mL, and 39.26 points for serum NSE, PNI score, and iMELD score. A combined prediction model of four factors demonstrated the highest predictive performance, with an AUC of 0.919 and a cut-off value of 0.23. Kaplan-Meier survival analysis revealed that patients with combined score of serum NSE, PNI score, HE grade, and iMELD cut-off value < 0.23 had a significantly higher 90-day survival rate compared to those with cut-off value≥0.23 (Log-Rank=265.567, P < 0.001).
Serum NSE, PNI score, HE grade, and iMELD score exhibit good value in predicting the short-term prognosis of patients with cirrhosis and overt HE, with an even higher predictive value when used in combination.
[1] |
中华医学会消化病学分会. 中国肝硬化临床诊治共识意见[J]. 临床肝胆病杂志, 2023, 39(9): 2057-2073.
|
[2] |
中华医学会肝病学分会. 肝硬化肝性脑病诊疗指南[J]. 中国肝脏病杂志: 电子版, 2018, 10(4): 17-32. doi: 10.3969/j.issn.1674-7380.2018.04.004
|
[3] |
ABBASY M, ZAGHLA H, ELHELBAWY M, et al. Predicting in-hospital mortality of cirrhotic patients hospitalized with hepatic encephalopathy[J]. Egypt Liver J, 2022, 12(1): 13. doi: 10.1186/s43066-022-00178-z
|
[4] |
YANG G, JUN D, HONG J, et al. Levels of S100 calcium binding protein B (S100B), neuron-specific enolase (NSE), and cyclophilin A (CypA) in the serum of patients with severe craniocerebral injury and multiple injuries combined with delirium transferred from the ICU and their prognostic value[J]. Annals of palliative medicine, 2021, 10(3): 3371-3378. doi: 10.21037/apm-21-424
|
[5] |
PENG P C, CHEN L J, SHEN Q J, et al. Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) score for predicting outcomes of breast cancer: a systematic review and meta-analysis[J]. Pak J Med Sci, 2023, 39(5): 1535-1541.
|
[6] |
MAHMOUD OSMAN Y, HASSAN M, ABDEL REHIM A E, et al. Nutritional assessment of cirrhotic patients with variable severity[J]. J Curr Med Res Pract, 2019, 4(2): 144. doi: 10.4103/JCMRP.JCMRP_14_18
|
[7] |
LUCA A, ANGERMAYR B, BERTOLINI G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis[J]. Liver Transpl, 2007, 13(8): 1174-1180. doi: 10.1002/lt.21197
|
[8] |
徐小元, 丁惠国, 李文刚, 等. 肝硬化诊治指南[J]. 实用肝脏病杂志, 2019, 22(6): 770-786. doi: 10.3969/j.issn.1672-5069.2019.06.004
|
[9] |
卞兆连, 邵建国, 薛红. CONUT联合CTP评分预测肝硬化合并肝性脑病患者近期预后的临床意义[J]. 胃肠病学, 2023, 28(1): 6-11. doi: 10.3969/j.issn.1008-7125.2023.01.002
|
[10] |
WU D, WANG X W, DING Y Y, et al. PNI, NLR and PLR combined detection prognosis of patients with chronic hepatitis C-associated cirrhosis complicated by T2DM[J]. J Infect Dev Ctries, 2023, 17(10): 1356-1361. doi: 10.3855/jidc.18157
|
[11] |
KRISHNAN A, WORETA T A, VAIDYA D, et al. MELD or MELD-Na as a predictive model for mortality following transjugular intrahepatic portosystemic shunt placement[J]. J Clin Transl Hepatol, 2023, 11(1): 38-44.
|
[12] |
LOUISSAINT J, DEUTSCH-LINK S, TAPPER E B. Changing epidemiology of cirrhosis and hepatic encephalopathy[J]. Clin Gastroenterol Hepatol, 2022, 20(8): S1-S8. doi: 10.1016/j.cgh.2022.04.036
|
[13] |
张滢, 朱月永. 肝性脑病相关临床治疗策略[J]. 中国临床医生杂志, 2019, 47(12): 1400-1402. doi: 10.3969/j.issn.2095-8552.2019.12.005
|
[14] |
王蕾, 李维泉, 陈力, 等. 糖组检测在肝脏疾病诊疗中的应用现状与未来展望[J]. 药学进展, 2021, 45(11): 827-834.
|
[15] |
齐洪武, 曾维俊, 刘岩松, 等. 神经元特异度烯醇化酶在中枢神经系统损伤中的应用研究进展[J]. 疑难病杂志, 2023, 22(10): 1106-1110. doi: 10.3969/j.issn.1671-6450.2023.10.019
|
[16] |
SUN Y X, WANG S, GAN S Q, et al. Serum neuron-specific enolase levels associated with connectivity alterations in anterior default mode network after mild traumatic brain injury[J]. J Neurotrauma, 2021, 38(11): 1495-1505. doi: 10.1089/neu.2020.7372
|
[17] |
KUREK K, SWIECZKOWSKI D, PRUC M, et al. Predictive performance of neuron-specific enolase (NSE) for survival after resuscitation from cardiac arrest: a systematic review and meta-analysis[J]. J Clin Med, 2023, 12(24): 7655. doi: 10.3390/jcm12247655
|
[18] |
刘宁静, 于慧静, 曹晓春. 门冬氨酸鸟氨酸联合乳果糖对老年肝性脑病疗效和NSE的影响[J]. 中南医学科学杂志, 2023, 51(4): 579-581.
|
[19] |
范静, 徐静, 袁雪. 利福昔明联合乳果糖治疗肝性脑病患者疗效及其血清S100B蛋白和神经元特异度烯醇化酶变化[J]. 实用肝脏病杂志, 2021, 24(1): 103-106.
|
[20] |
SEHGAL P, SHARMA S, SOOD A, et al. Assessment and prediction of malnutrition and sarcopenia in liver cirrhosis patients[J]. Nutrire, 2023, 48(1): 6. doi: 10.1186/s41110-023-00189-9
|
[21] |
ROMEIRO F G, AUGUSTI L. Nutritional assessment in cirrhotic patients with hepatic encephalopathy[J]. World J Hepatol, 2015, 7(30): 2940-2954. doi: 10.4254/wjh.v7.i30.2940
|
[22] |
LATTANZI B, D'AMBROSIO D, MERLI M. Hepatic encephalopathy and sarcopenia: two faces of the same metabolic alteration[J]. J Clin Exp Hepatol, 2019, 9(1): 125-130. doi: 10.1016/j.jceh.2018.04.007
|
[23] |
ONODERA T, GOSEKI N, KOSAKI G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients[J]. Nihon Geka Gakkai Zasshi, 1984, 85(9): 1001-1005.
|
[24] |
朱铭钰, 朱静, 方兴超, 等. 预后营养指数与癌症预后的关联研究: 一项伞状评价[J]. 实用预防医学, 2023, 30(10): 1204-1210. doi: 10.3969/j.issn.1006-3110.2023.10.012
|
[25] |
WANG X Y, KANG Z L, WANG Y C, et al. Application of prognostic nutritional index in the predicting of prognosis in young adults with acute ischemic stroke[J]. World Neurosurg, 2023, 178: e292-e299. doi: 10.1016/j.wneu.2023.07.045
|
[26] |
ZHUANG C L, CHEN Y D, RUAN J S, et al. Correlation between the prognostic nutritional index and outcomes in older patients aged ≥60 years with chronic heart failure[J]. Int J Clin Pharm, 2023, 45(1): 163-173. doi: 10.1007/s11096-022-01501-9
|
[27] |
孔钦香, 盛吉芳. 慢性乙肝肝硬化患者肝性脑病不同分级与肝脏储备功能的相关性[J]. 中国微生态学杂志, 2023, 35(2): 190-196.
|
[28] |
CHEN P C, CHEN B H, HUANG C H, et al. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis[J]. Eur J Gastroenterol Hepatol, 2019, 31(10): 1256-1263. doi: 10.1097/MEG.0000000000001481
|